SCHEMBL19284533

SCHEMBL19284533

COC(=O)c1ccc2c(c1)CN(c1ccc(OCOCC[Si](C)(C)C)cc1)CC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MRGPRX4 Q96LA9 1/20 0.43
▸ OPRM1 P35372 1/20 0.39
▸ OPRD1 P41143 1/20 0.39
▸ OPRK1 P41145 1/20 0.39
▸ OGFRL1 Q5TC84 1/20 0.39
▸ MAPK1 P28482 3/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ MAPT P10636 1/20 0.38
▸ TSHR P16473 4/20 0.38
▸ TP53 P04637 2/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ SCN9A Q15858 1/20 0.37
▸ SRD5A1 P18405 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19284497 0.78 ALDH1A1 (0.49) MRGPRX4OPRM1OPRD1OPRK1OGFRL1
SCHEMBL28480511 0.77 MAPT (0.63) SMN1; SMN2ALDH1A1MAPTKDM4EKMT2A
SCHEMBL19801995 0.74 DDR1 (0.51) OPRM1OPRD1OPRK1OGFRL1SMN1; SMN2
SCHEMBL6041694 0.74 MAPT (0.48) SMN1; SMN2ALDH1A1MAPTKDM4ERAB9A
SCHEMBL14158144 0.72 ESR1 (0.54) ALDH1A1TP53SCN9ALIPENPC1
SCHEMBL17869278 0.72 NPC1 (0.58) OPRM1OPRD1OPRK1OGFRL1SMN1; SMN2
SCHEMBL6044419 0.72 CYSLTR1 (0.49) MRGPRX4SMN1; SMN2ALDH1A1MAPTTP53
SCHEMBL30109340 0.70 LIPE (0.58) MAPK1ALDH1A1MAPTTSHRKDM4E
SCHEMBL15000524 0.70 OPRM1 (0.41) OPRM1OPRD1OPRK1OGFRL1MAPK1
SCHEMBL16775545 0.69 OPRM1 (0.42) OPRM1OPRD1OPRK1OGFRL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017147047-A1 FXR MODULATORS AND METHODS OF THEIR USE ALIOS BIOPHARMA, INC. (US) 2017-08-31 — — WO disclosed
Send feedback